TuHURA Biosciences Inc.

NASDAQ: HURA · Real-Time Price · USD
2.95
0.19 (6.88%)
At close: Aug 15, 2025, 12:14 PM

TuHURA Biosciences Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
116.71K n/a n/a n/a
Gross Profit
-116.71K n/a n/a n/a
Operating Income
-17.65M -29.76M -9.93M -7.25M
Interest Income
361.63K 89.67K 57.35K n/a
Pretax Income
-21.68M -29.32M -9.37M -7.02M
Net Income
-21.68M -29.32M -9.37M -7.02M
Selling & General & Admin
4.2M 4.14M 2.01M 2.38M
Research & Development
13.34M 9.4M 7.93M 4.88M
Other Expenses
n/a 16.22M n/a n/a
Operating Expenses
17.53M 29.76M 9.93M 7.25M
Interest Expense
4.14M 18.69K n/a 629.29K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-17.65M 29.76M 9.93M 7.25M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
186.63K 420.3K 46.28K 27.9K
Shares Outstanding (Diluted)
186.63K 420.3K 46.28K 27.9K
EPS (Basic)
-116.18 -69.75 -0.22 -251.47
EPS (Diluted)
-116.18 -69.75 -0.22 -251.47
EBITDA
-17.43M -29.12M -9.56M -6.01M
EBIT
-17.54M -29.3M -9.93M -6.39M
Depreciation & Amortization
116.71K 177.38K 373.09K 380.69K